Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Second-line Chemotherapy in Advanced Gastric Cancer
NCT00821990Phase 3Completed
- Sponsor
- Samsung Medical Center
- Start
- Sep 2008
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel, irinotecan in gastric cancer (GC), sponsored by Samsung Medical Center. Started Sep 2008; status: completed.
02
Drugs
docetaxelirinotecan
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00821990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00821990.